Emergent BioSolutions
EBS
#6766
Rank
C$0.88 B
Marketcap
C$16.61
Share price
-1.24%
Change (1 day)
29.48%
Change (1 year)

Emergent BioSolutions (EBS) - Cash on Hand

Cash on Hand as of September 2025 : C$0.34 Billion

According to Emergent BioSolutions 's latest financial reports the company has C$0.34 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Emergent BioSolutions - Cash on Hand chart (from 2004 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.14 B-3.63%
2023-12-31C$0.14 B-83.01%
2022-12-31C$0.87 B18.76%
2021-12-31C$0.73 B-7.32%
2020-12-31C$0.79 B261.48%
2019-12-31C$0.21 B43.39%
2018-12-31C$0.15 B-31.82%
2017-12-31C$0.22 B-38.56%
2016-12-31C$0.36 B-14.69%
2015-12-31C$0.42 B31.39%
2014-12-31C$0.32 B70.51%
2013-12-31C$0.19 B35.52%
2012-12-31C$0.14 B-5.06%
2011-12-31C$0.14 B-13.22%
2010-12-31C$0.17 B57.88%
2009-12-31C$0.10 B-2.63%
2008-12-31C$0.11 B5.45%
2007-12-31C$0.10 B18.55%
2006-12-31C$88.97 M110.56%
2005-12-31C$42.25 M415.77%
2004-12-31C$8.19 M
2002-12-31C$7.72 M-17.17%
2001-12-31C$9.32 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Merck
MRK
C$25.42 B 7,319.14%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
C$0.24 B-29.96%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$6.20 B 1,710.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
C$0.81 B 137.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$20.91 B 6,003.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.07 B 797.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
C$14.69 M-95.71%๐Ÿ‡บ๐Ÿ‡ธ USA